发明名称 PIPERAZINE DERIVATIVE
摘要 The object is to provide a compound which can specifically bind to an NR1/NR2B receptor and can be used as an antagonist of an NR2B receptor. It is found that a piperazine derivative represented by the formula (I) can specifically bind to an NR1/NR2B receptor and can be used as an antagonist of an NR2B receptor. Thus, disclosed is a compound represented by the formula (I), a pharmaceutically acceptable salt thereof, or a solvate of the compound or the pharmaceutically acceptable salt thereof. (I) wherein R1's independently represent a C1-C3 alkyl or the like; m represents an integer of 0 to 4; X represents -N(R4)-C(=O)-C(=O)-, -N(R4)-(CR5R6)p-C(=O)-, -N(R4)-C(=O)-(CR7R8)q- or -C(=O)-N(R4)-(CR7R8)q-; p and q independently represent an integer of 1 to 3; R4, R5, R6, R7 and R8 independently represent a hydrogen or a lower alkyl; A1 represents a benzoxazolinone or the like; and A2 represents a phenyl which may be substituted or the like.
申请公布号 WO2009025265(A1) 申请公布日期 2009.02.26
申请号 WO2008JP64731 申请日期 2008.08.19
申请人 SHIONOGI & CO., LTD.;MASUI, MORIYASU;TOMIDA, MINORU;KOBAYASHI, NAOTAKE;ANAN, KOUSUKE;TAZAWA, AYA;HATA, KAYOKO 发明人 MASUI, MORIYASU;TOMIDA, MINORU;KOBAYASHI, NAOTAKE;ANAN, KOUSUKE;TAZAWA, AYA;HATA, KAYOKO
分类号 C07D209/34;A61K31/496;A61P9/10;A61P25/02;A61P25/04;A61P25/08;A61P25/14;A61P25/16;A61P25/28;A61P43/00;C07D215/22;C07D235/26;C07D263/58;C07D401/12;C07D401/14;C07D403/12;C07D413/12;C07D413/14;C07D487/08;C07D498/04 主分类号 C07D209/34
代理机构 代理人
主权项
地址